DGI
RDHL
Disciplined Growth Investors’s Redhill Biopharma RDHL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-810,646
| Closed | -$705K | – | 74 |
|
|
2022
Q2 | $705K | Sell |
810,646
-1,139,356
| -58% | -$991K | 0.02% | 70 |
|
|
2022
Q1 | $4.91M | Buy |
1,950,002
+14,413
| +0.7% | +$36.3K | 0.11% | 63 |
|
|
2021
Q4 | $4.99M | Sell |
1,935,589
-40,887
| -2% | -$105K | 0.1% | 62 |
|
|
2021
Q3 | $9.05M | Hold |
1,976,476
| – | – | 0.18% | 60 |
|
|
2021
Q2 | $13.6M | Buy |
1,976,476
+147,889
| +8% | +$1.02M | 0.26% | 57 |
|
|
2021
Q1 | $13.4M | Sell |
1,828,587
-200,608
| -10% | -$1.47M | 0.27% | 55 |
|
|
2020
Q4 | $16.4M | Sell |
2,029,195
-82,256
| -4% | -$665K | 0.32% | 55 |
|
|
2020
Q3 | $21.6M | Sell |
2,111,451
-6,366
| -0.3% | -$65.1K | 0.51% | 50 |
|
|
2020
Q2 | $14.2M | Buy |
2,117,817
+413,328
| +24% | +$2.77M | 0.34% | 56 |
|
|
2020
Q1 | $7.72M | Sell |
1,704,489
-147,873
| -8% | -$670K | 0.18% | 61 |
|
|
2019
Q4 | $11.2M | Buy |
1,852,362
+707,348
| +62% | +$4.29M | 0.19% | 63 |
|
|
2019
Q3 | $8.06M | Buy |
1,145,014
+4,550
| +0.4% | +$32K | 0.15% | 67 |
|
|
2019
Q2 | $7.41M | Sell |
1,140,464
-9,471
| -0.8% | -$61.6K | 0.14% | 67 |
|
|
2019
Q1 | $9.56M | Buy |
1,149,935
+6,934
| +0.6% | +$57.6K | 0.17% | 67 |
|
|
2018
Q4 | $6.34M | Buy |
1,143,001
+1,109,567
| +3,319% | +$6.16M | 0.13% | 72 |
|
|
2018
Q3 | $295K | Buy |
+33,434
| New | +$295K | ﹤0.01% | 86 |
|